Introduction: Cnidoscolus quercifolius Pohl (Euphorbiaceae) is a Brazilian medicinal plant, popularly known as "favela", "faveleira" and "urtiga-branca". In folk medicine, its leaves and stem barks are used to treat urinary tract infections. In this study, we report the isolation and characterization of a mixture of two lupane-type triterpenes and one bis-nor-diterpene from the hexane extract of the stem barks.
Introduction
The use of antibiotics is widely described in many clinical situations, including in the control of infections during invasive surgeries, in cancer chemotherapy and in the treatment of immune-compromised patients [1] . In recent years, antibiotic resistance has become a serious health problem, leading to the emergence of microorganisms resistant to conventional chemotherapy [2] .
In this sense, infectious diseases caused by antibiotic resistant microorganisms have been frequently reported [3, 4] . For this reason, the search for new antimicrobial molecules from natural products remains an effective alternative [5] [6] [7] .
Euphorbiaceae is a pantropical family containing approximately 300 genera and 7000 species, including trees, shrubs and herbs, of which 70 genera and 1000 species occur in Brazil [8] .
The neotropical genus Cnidoscolus Pohl is represented by 70 species [9, 10] . In Brazil, there are 42
Cnidoscolus species distributed in different geographical areas, such as Cerrado, Atlantic Forest, Amazon and Caatinga biome [11, 12] .
Cnidoscolus quercifolius Pohl (syn.: Cnidoscolus phyllacanthus (Mull. Arg.) Pax & L.
Hoffm.) is a Brazilian medicinal plant from Caatinga biome, popularly known as "favela", "faveleira" and "urtiga-branca". In folk medicine, its leaves and stem barks are used to treat injury, urinary tract infections and inflammatory processes [13] . Previous pharmacological investigations evaluated the antinociceptive [14] , anti-inflammatory [15] , antioxidant [16, 17] , antiproliferative [18, 19] and antibacterial [17, 20] effects of crude extracts from C. quercifolius.
From a phytochemical point of view, lupane-type triterpenes and bis-nor-diterpenes have been reported in C. quercifolius [21] . New tricyclic benzocyclohepten diterpenes, called favelins, were isolated from stem barks extracts [22] . New cyclopropane and cyclobutene tetracyclic derivatives, such as favelanone and neofavelanone, respectively, were also described in previous phytochemical studies [23, 24] . Apparently, these diterpenes occur exclusively in C. quercifolius.
Although C. quercifolius extracts have been investigated for their antibacterial potential, there are no reports on the antibacterial activity of compounds isolated from this species.
Considering the popular use of this plant for the treatment of infections, the present study describes the antibacterial activity of terpenoids isolated from the stem barks of C. quercifolius against pathogenic strains. 
Materials and methods

Plant material
Extraction and isolation
The dried and pulverized stem barks (534 g) were extracted with hexane (2.0 L, four times), followed by methanol (2.0 L, four times), yielding 8.7 and 18.5 g of hexane and methanol extracts (Hex-Cq and MeOH-Cq, respectively) after removal of the solvents under vacuum. An aliquot of Hex-Cq (7.0 g) was fractionated by chromatography column, using silica gel 60 (Sigma-Aldrich ® , 230-240 mesh) as stationary phase. Hexane, chloroform (CHCl 3 ), ethyl acetate (AcOEt) and methanol (MeOH) were used as eluents, in increasing order of polarity. In total, 42 fractions (125 ml each) were collected and reunited in 13 different groups (groups A-M), after TLC analysis.
Group D (eluted with hexane/CHCl 3 2.5:7.5, v/v) showed the formation of white crystals (635 mg) soluble in chloroform, which was subsequently identified as a mixture of two compounds (1 and 2).
Group F (eluted with CHCl 3 ) was fractionated by preparative TLC, using hexane/AcOEt (9:1, v/v) as eluent, leading to the isolation of compound 3 (13.7 mg, yellow crystals soluble in chloroform).
Spectroscopic analysis
NMR spectra ( 1 H, 13 
Determination of minimum inhibitory concentration (MIC)
Antibacterial activity was evaluated by the microdilution method, as recommended by National Committee for Clinical Laboratory Standards [25] . Stock solutions of extracts (Hex-Cq and MeOH-Cq, 20 mg.ml -1 ) and isolated compounds (1/2 and 3, 2 mg.ml -1 ) were prepared in 2% 
Determination of minimum bactericidal concentration (MBC)
To determine MBC, an aliquot (10 µl) was withdrawn from each well containing extracts or isolated compounds and transferred to Petri dishes containing agar Müller-Hinton. Plates were incubated for 24 h in the same conditions previously described. The absence of bacterial colony for a given concentration indicates that it was able to kill 99.9% or more of bacterial inoculum used.
MBC was defined as the lowest concentration of extracts or compounds that visibly inhibited the bacterial colony production in three independent experiments.
Results
Structural characterization of isolated compounds
TLC analysis revealed a good degree of purity for the isolated compounds. Compound 3
showed fluorescence at 365 nm, suggesting the presence of an aromatic ring in its structure. In 7 addition, TLC analysis using sulfuric vanillin revealed the presence of purple spots, indicating that these compounds were terpenes (Fig. 1) . 1 H NMR spectra for compound 3 displayed two singlets at δ 7.62 (H-1) and 6.59 (H-4), attributed to two protons para-related, and another singlet signal at 6.29 (H-11), attributed to a vinyl hydrogen. 13 C NMR spectra showed a signal at δ 201. confirmed the substitution pattern of the aromatic ring and all 1 H and 13 C assignments. These data allowed the unambiguous structural characterization of compound 3 as the bis-nor-diterpene phyllacanthone [21] . All the spectra data obtained for each compound are shown in the supplementary material. 
Antibacterial activity 9
The MIC values determined for the samples are presented in -1 , suggesting that these molecules also exert a bactericidal effect (Table 2 ). In this case, compound 3 was more effective than gentamicin against E. faecalis and E.
coli. 
indicates bacterial growth in all tested concentrations (n=3).
Discussion
Compounds 1 and 2 have previously been described in C. quercifolius [18, 21] . In fact, these compounds are frequently obtained as a mixture, due to its structural similarity. This mixture has also been reported in C. vitifolius [26] . Other lupane-type triterpenes were reported in C.
quercifolius, such as lupeol [21] and lupeol-3β-O-nanoate [18] . Compound 3 is a bis-nor-diterpene commonly found in C. quercifolius [18, 21, 27] . Also known as faveline-methyl-ether, phyllacanthone (3) was one of the first isolated substances from this plant. To date, there are no reports of other species that present this chemical constituent in its composition, being considered of exclusive occurrence in C. quercifolius. A recent study demonstrated the cytotoxic potential of phyllacanthone (3) against human pro-myelocytic leukemia (HL-60), human lung carcinoma (NCI-H292) and human breast adenocarcinoma (MCF-7) cells [18] . However, these compounds have not been sufficiently investigated for their biological activities.
In this paper, we evaluated the antibacterial activity of extracts (Hex-Cq and MeOH-Cq) and isolated compounds (1/2 and 3) against pathogenic bacteria strains. In general, compounds 1/2 and 3 were effective against all the microorganisms used. Interestingly, compound 3 was more effective 11 than the standard drug (gentamicin) against E. faecalis and E. coli strains. Although it is present in the human gastrointestinal microbiota, E. faecalis is considered an opportunistic pathogen associated with hospital-acquired wound, bloodstream, and urinary tract infections [28] . Similarly, E. coli is also among the most frequent pathogens found in urinary tract infections. These microorganisms are able to persist in the host for long periods through formation of biofilm that prevents phagocytosis by immune system cells [29] . In addition, both microorganisms have developed multidrug resistance mechanisms in recent years, making it difficult to control associated infections [30, 31] . In this context, the search for bioactive molecules that can treat E. faecalis and E. coli infections remains a current challenge.
Terpenoids are admittedly used in the treatment of bacterial infections. Due to their lipophilic character, terpenoids can easily interact with the bacterial wall, interfering with the biosynthesis of its components. Furthermore, these compounds penetrate the bacterial cell and may also interfere with protein synthesis and DNA replication and repair mechanisms. In recent years, terpenoids have shown ability to enhance the effect of conventional antibacterial drugs. This has been an extremely useful strategy in controlling antibiotic resistance. These molecules have modulated the effect of antibacterial agents either by promoting direct cytotoxicity or by increasing their residence time in the cell, ensuring greater pharmacological activity at lower concentrations [32] . In this sense, compounds isolated from C. quercifolius may play an important role not only in the control of bacterial infections, especially those caused by E. faecalis and E. coli, but also in the control of multidrug resistance mechanisms. In vivo studies should be performed to determine the toxicity of these molecules, as well as their pharmacokinetic properties, associated or not with other antibacterial agents.
Peixoto-Sobrinho et al. [20] have reported the antibacterial activity of four Cnidoscolus species (C. infestus Pax and K. Hoffman, C. pubescens Pohl, C. urens (L.) Arthur and C.
quercifolius) using the agar diffusion method. In this study, C. quercifolius extracts were the most bioactive, showing a relevant bacteriostatic effect against S. aureus. However, this was a 12 preliminary study conducted with crude extracts. In the present paper, we report the isolation of antibacterial compounds from C. quercifolius extracts for the first time. We believe that these compounds are responsible, at least in part, for the antibacterial potential observed for the extracts.
These findings suggest that this plant may be considered a promising source of new antibacterial agents and further studies should be performed in order to characterize their mode of action.
Conclusions
In this phytochemical investigation, we report the isolation and characterization of three terpenoids from the stem barks of C. quercifolius: lupeol-3β-O-cinnamate (1), lupeol-3β-Odihydrocinnamate and phyllacanthone (3). The isolated substances showed significant antibacterial activity, mainly compound 3. These results indicate that C. quercifolius has antibacterial potential, supporting its use in folk medicine in the treatment of urinary tract infections.
